The largest database of trusted experimental protocols

Glycerol phosphate buffered salt solution

Manufactured by Thermo Fisher Scientific

Glycerol/phosphate buffered salt solution is a multi-purpose buffer solution used in various laboratory applications. It provides a consistent pH environment to maintain the stability and activity of biological samples and reagents. The solution contains glycerol and phosphate-based salts to create a physiologically relevant buffer system.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using glycerol phosphate buffered salt solution

1

Oral Vaccine Production Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vaccine was produced according to published protocol 18 (link) bypassing the lyophilization step 25 (link). Briefly, pET9c-ospA-transformed and untransformed E. coli BL21(DE3)pLysS were cultured in TBY media supplemented with 50μg/ml Kan, and grown at 37°C, 220 rpm, for about 3h to reach an OD600=0.8. Protein expression was induced with 1mM IPTG/ml during 3h to reach OD600=1 (~109E. coli cells/ml). The cells were harvested by centrifugation at 4000×g for 10 min at 4°C and the biomass was resuspended in 20% glycerol/phosphate buffered salt solution (Gibco, Grand Island, NY) in 1% of the initial volume. Cell suspensions in aliquots of 1 ml were snap frozen in a dry ice bath and stored at −80°C. Aliquots of 300μl (~3×108 cells) were thawed and placed in a ball tipped disposable feeding needle (Fisher Scientific, Pittsburgh, PA) for oral gavage inoculation.
+ Open protocol
+ Expand
2

Oral Immunization of Recombinant E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant E. coli was cultured in TBY supplemented with Kn, and grown at 37°C, 225 rpm, to an OD600 of 0.8. Protein expression was induced with 1 mM IPTG during 3h. The cells were harvested by centrifugation at 4000xg for 10 min at 4°C and resuspended in 20% glycerol/phosphate buffered salt solution (Gibco, Grand Island, NY) in 1% of the initial volume. Cell suspensions in aliquots of 2 ml were frozen quickly in a dry ice bath and stored at -80°C. Aliquots of recombinant E. coli were thawed at 4°C and 400 μl (109 cells) were placed in a ball-tipped syringe for oral gavage inoculation. Groups of female C3H/HeN mice were immunized by intragastric inoculation of induced recombinant E. coli or with the empty vector (Ec) as controls. Mice received the first immunization, twice daily, for 10 days (days 1–5 and 8–12), rested for two weeks, received the first boost for 5 days (days 29–33), rested for another week and then received a second boost for 5 days (days 43–47). On day 73, mice were terminated for collection of bronchoalveolar lavage (BAL) or challenged. Low amounts of mouse blood (up to 50 μl) were obtained via tail nick on the following days: 0, 28, 42, 73, 105, 135 and 170 after immunization. Stool (GUT, gastrointestinal tract secretions), bronchoalveolar lavage (BAL) and vaginal lavage (VAL) were collected on day 73 after immunization.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!